ALLY Stock Analysis: Ally Financial | NYSE
Credit Services | NYSE, USA | Market Cap: 14.171m USD | 12M Return: 13.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 144M
EPS Trend: -37.8%
Qual. Beats: 0
Rev. Trend: 34.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ally Financial Inc. (NYSE: ALLY) is a Detroit-based digital financial-services company operating in the United States and Canada through three main segments: Automotive Finance, Insurance, and Corporate Finance. Its Automotive Finance segment offers retail installment contracts, dealer floorplan financing, lease products, and fleet financing, while the Insurance segment provides vehicle service contracts, maintenance contracts, GAP coverage, and commercial dealer insurance through the automotive dealer channel. The Corporate Finance segment delivers senior secured, asset-based, and leveraged loans to middle-market companies, along with commercial real estate financing for nursing facilities, senior housing, and medical office buildings. Ally also runs a direct banking platform offering deposits, securities brokerage, and investment advisory services, alongside treasury and investment portfolio management activities. Founded in 1919 and formerly known as GMAC Inc., Ally rebranded in May 2010 and is classified within the Consumer Finance sub-industry of the Financials sector, positioning it as one of the larger U.S. providers of auto financing and a notable digitally focused challenger bank.
- Auto loan credit losses rise as used car prices soften
- Net interest margin compresses as Fed cuts rates
- Retail deposit growth funds loan book expansion
| Net Income: 1.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.32 > 1.0 |
| NWC/Revenue: -811.3% < 20% (prev -801.9%; Δ -9.33% < -1%) |
| CFO/TA 0.02 > 3% & CFO 4.17b > Net Income 1.40b |
| Net Debt (-7.34b) to EBITDA (3.15b): -2.33 < 3 |
| Current Ratio: 0.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (313.2m) vs 12m ago 1.36% < -2% |
| Gross Margin: 48.87% > 18% (prev 42.12%; Δ 6.75% > 0.5%) |
| Asset Turnover: 8.01% > 50% (prev 8.11%; Δ -0.10% > 0%) |
| Interest Coverage Ratio: 0.28 > 6 (EBIT TTM 1.74b / Interest Expense TTM 6.25b) |
| A: -0.64 (Total Current Assets 31.7b - Total Current Liabilities 159b) / Total Assets 197b |
| B: 0.00 (Retained Earnings 827.0m / Total Assets 197b) |
| C: 0.01 (EBIT TTM 1.74b / Avg Total Assets 195b) |
| D: 0.09 (Book Value of Equity 15.6b / Total Liabilities 182b) |
| Altman-Z'' = -4.06 = D |
| DSRI: 0.36 (Receivables 930.0m/2.60b, Revenue 15.7b/15.7b) |
| GMI: 0.86 (GM 42.12% / 48.87%) |
| AQI: 1.00 (AQ_t 0.79 / AQ_t-1 0.79) |
| SGI: 1.00 (Revenue 15.7b / 15.7b) |
| TATA: -0.01 (NI 1.40b - CFO 4.17b) / TA 197b) |
| Beneish M = -3.68 (Cap -4..+1) = AAA |
As of July 09, 2026, the stock is trading at USD 44.48 with a total of 2,583,376 shares traded. Over the past week, the price has changed by -3.20%, over one month by +4.96%, over three months by +7.37% and over the past year by +13.54%.
Current recommended Stop Loss: 42.90 (which is 3.6% or 1.3 ATR below the current price).
Ally Financial has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy ALLY.
- StrongBuy: 10
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 53.6 | 20.5% |
P/E Trailing = 11.2209
P/E Forward = 8.5034
P/S = 1.8434
P/B = 1.0457
P/EG = 0.4887
Revenue TTM = 15.7b USD
EBIT TTM = 1.74b USD
EBITDA TTM = 3.15b USD
Long Term Debt = 17.3b USD (from longTermDebt, last quarter)
Short Term Debt = 4.13b USD (from shortTermDebt, last quarter)
Debt = 21.7b USD (from shortLongTermDebtTotal, last quarter) + Leases 121.0m
Net Debt = -7.34b USD (calculated: Debt 21.7b - CCE 29.1b)
Enterprise Value = 6.83b USD (14.2b + Debt 21.7b - CCE 29.1b)
Interest Coverage Ratio = 0.28 (Ebit TTM 1.74b / Interest Expense TTM 6.25b)
EV/FCF = 621.1x (Enterprise Value 6.83b / FCF TTM 11.0m)
FCF Yield = 0.16% (FCF TTM 11.0m / Enterprise Value 6.83b)
FCF Margin = 0.07% (FCF TTM 11.0m / Revenue TTM 15.7b)
Net Margin = 8.92% (Net Income TTM 1.40b / Revenue TTM 15.7b)
Gross Margin = 48.87% ((Revenue TTM 15.7b - Cost of Revenue TTM 8.00b) / Revenue TTM)
Gross Margin QoQ = 48.96% (prev 48.01%)
Tobins Q-Ratio = 0.03 (Enterprise Value 6.83b / Total Assets 197b)
Interest Expense / Debt = 28.78% (Interest Expense 6.25b / Debt 21.7b)
Taxrate = 19.54% (339.0m / 1.74b)
NOPAT = 1.40b (EBIT 1.74b * (1 - 19.54%))
Current Ratio = 0.20 (Total Current Assets 31.7b / Total Current Liabilities 159b)
Debt / Equity = 1.39 (Debt 21.7b / totalStockholderEquity, last quarter 15.6b)
Debt / EBITDA = -2.33 (Net Debt -7.34b / EBITDA 3.15b)
Debt / FCF = -667.2 (out of range, set to none) (Net Debt -7.34b / FCF TTM 11.0m)
Total Stockholder Equity = 15.2b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.71% (Net Income 1.40b / Total Assets 197b)
RoE = 9.19% (Net Income TTM 1.40b / Total Stockholder Equity 15.2b)
RoCE = 5.33% (EBIT 1.74b / Capital Employed (Equity 15.2b + L.T.Debt 17.3b))
RoIC = 3.33% (NOPAT 1.40b / Invested Capital 41.9b)
WACC = 18.19% (E(14.2b)/V(35.9b) * Re(10.59%) + D(21.7b)/V(35.9b) * Rd(28.78%) * (1-Tc(0.20)))
Discount Rate = 10.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 77.78 | Cagr: 0.93%
[DCF] Terminal Value 45.21% ; FCFF base≈259.4m ; Y1≈227.5m ; Y5≈183.8m
[DCF] Fair Price = 27.70 (EV 1.15b - Net Debt -7.34b = Equity 8.49b / Shares 306.5m; r=18.19% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -37.75 | EPS CAGR: -10.87% | SUE: 0.42 | # QB: 0
Revenue Correlation: 34.49 | Revenue CAGR: 2.55% | SUE: 0.77 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.25 | Chg30d=-1.63% | Revisions=-22% | Analysts=16
EPS next Quarter (2026-09-30): EPS=1.46 | Chg30d=+0.55% | Revisions=+22% | Analysts=16
EPS current Year (2026-12-31): EPS=5.31 | Chg30d=-0.28% | Revisions=-29% | GrowthEPS=+39.4% | GrowthRev=+13.3%
EPS next Year (2027-12-31): EPS=6.49 | Chg30d=+0.03% | Revisions=-17% | GrowthEPS=+22.1% | GrowthRev=+6.5%
[Analyst] Revisions Ratio: -14% (up=8, down=11)